Date of dispatch of this notice: 06-05-2021
External Reference: 2021-586835
TED Reference: 2021/S 091-237117
Contract award notice
Information
Published
Contract award notice
Bekendtgørelse om indgåede kontrakter
Resultat af udbudsproceduren
Direktiv 2014/24/EU
Del I: Ordregivende myndighed
I.1)
Navn og adresser
NHS Arden and GEM Commissioning Support Unit
NHS Arden and GEM Commissioning Support Unit
Cardinal Square
Derby
DE1 3QT
UK
Kontaktperson:
Mark Didcock
Telefon:
+44 7970633382
E-mail:
mark.didcock@nhs.net
NUTS-kode:
UKF -
EAST MIDLANDS (ENGLAND)
Overordnet internetadresse:
https://www.ardengemcsu.nhs.uk/
Internetadresse for køberprofilen:
https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/68205
I.4)
Type ordregivende myndighed
Offentligretligt organ
I.5)
Hovedaktivitet
Sundhed
Del II: Genstand
II.1)
Udbuddets omfang
II.1.1)
Betegnelse
Provision of Risk Stratification Tool
Sagsnr.:
AGEMCSU/TRANS/20/902
II.1.2)
Hoved-CPV-kode
48517000
-
II.1.3)
Kontrakttype
Varer
II.1.4)
Kort beskrivelse
NHS Arden & GEM CSU seeks competitive offers for the supply, installation, support and maintenance of Risk Stratification Algorithms within a Tool.
II.1.6)
Oplysninger om delkontrakter
Kontrakten er opdelt i delkontrakter:
nej
II.1.7)
Udbuddets samlede værdi
Værdi eksklusive moms:
601500.00
GBP
II.2)
Beskrivelse
II.2.2)
Supplerende CPV-kode(r)
48460000
-
II.2.3)
Udførelsessted
NUTS-kode:
UKF -
EAST MIDLANDS (ENGLAND)
II.2.4)
Beskrivelse af udbuddet
NHS Arden & GEM CSU seeks competitive offers for the supply, installation, support and maintenance of Risk Stratification Algorithms within a Tool. The period covered will be 2 years (with an option to extend for a further 1 years) on a call off contract. The total cost should not exceed £410k for 24 months with prices paid for usage per head of population.
Currently our risk stratification covers a population of just over 1million with the potential to increase to 3.9 million population.
Briefly the two main use cases are:
Patient level risk stratification – The outputs will be used by clinicians for supporting direct patient care. Each patient’s overall morbidity and risk of particular outcomes is produced.
Population level risk profiling – The outputs will be used by non-clinical staff for population health purposes. Disease prevalence and morbidity distribution across the wider population is produced which can be used to inform planning, benchmarking and service redesign activities.
The Risk Stratification algorithms will be applied within an AGEM tool for the purpose of identification of impactable individual patients and cohorts of patients for clinical intervention and the provision of segmented data for the generation of analytical insight.
Currently our risk stratification covers a population of just over 1million with the potential to increase to 3.9 million population.
Briefly the two main use cases are:
Patient level risk stratification – The outputs will be used by clinicians for supporting direct patient care. Each patient’s overall morbidity and risk of particular outcomes is produced.
Population level risk profiling – The outputs will be used by non-clinical staff for population health purposes. Disease prevalence and morbidity distribution across the wider population is produced which can be used to inform planning, benchmarking and service redesign activities.
The Risk Stratification algorithms will be applied within an AGEM tool for the purpose of identification of impactable individual patients and cohorts of patients for clinical intervention and the provision of segmented data for the generation of analytical insight.
II.2.5)
Tildelingskriterier
de nedenfor anførte kriterier
Kvalitetskriterium
-
Navn:
Technical Criteria
/
Vægtning:
70
Omkostningskriterium
-
Navn:
Financial Criteria
/
Vægtning:
30
II.2.11)
Oplysninger om optioner
Optioner:
ja
Beskrivelse af optioner:
Option to extend for a further 12 months.
II.2.13)
Oplysninger om EU-midler
Udbuddet vedrører et EU-finansieret projekt og/eller program:
nej
Del IV: Procedure
IV.1)
Beskrivelse
IV.1.1)
Proceduretype
Offentligt udbud
IV.1.8)
Oplysninger om GPA-aftalen om offentlige udbud
Dette udbud er omfattet af GPA-aftalen
: ja
IV.2)
Administrative oplysninger
IV.2.1)
Tidligere offentliggørelse om samme kontrakt
Bekendtgørelsens nummer i EUT S: 2020/S 205-500534
Del V: Kontrakttildeling
Kontraktnr.: 1
Betegnelse: Provision of Risk Stratification Tool
V.2)
Kontrakttildeling
V.2.1)
Dato for indgåelse af kontrakten
28-04-2021
V.2.2)
Oplysninger om tilbud
Antal modtagne tilbud:
1
Antal tilbud modtaget fra SMV'er:
0
Antal tilbud modtaget fra tilbudsgivere fra andre EU-medlemsstater:
0
Antal tilbud modtaget fra tilbudsgivere fra ikke-EU-medlemsstater:
1
Antal tilbud modtaget elektronisk:
1
Kontrakten er blevet tildelt en sammenslutning af økonomiske aktører
:
nejV.2.3)
Kontrahentens navn og adresse
Johns Hopkins HealthCare LLC
750 East Pratt Street, MD
Baltimore
21202
US
NUTS-kode:
US -
United States
Kontrahenten er en SMV : nej
V.2.4)
Oplysninger om kontraktens/delkontraktens værdi (eksklusive moms)
Kontraktens/delkontraktens oprindeligt anslåede samlede værdi:
601500.00
GBP
Laveste bud:
601500.00
GBP
/
Højeste bud:
601500.00
GBP
taget i betragtning
Del VI: Supplerende oplysninger
VI.4)
Klageprocedurer
VI.4.1)
Organ med ansvar for klageprocedurerne
Arden & GEM Commissioning Support Unit
Cardinal Square
Derby
DE1 3QT
UK
Telefon:
+44 7970633382